Vapotherm Inc (NYSE:VAPO) Director Anthony L. Arnerich bought 10,000 shares of the business’s stock in a transaction that occurred on Friday, August 2nd. The shares were acquired at an average price of $14.34 per share, for a total transaction of $143,400.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
NYSE:VAPO traded down $0.24 during mid-day trading on Monday, hitting $14.32. 68,789 shares of the company’s stock were exchanged, compared to its average volume of 50,660. The stock’s 50 day moving average is $20.08. The company has a debt-to-equity ratio of 1.42, a current ratio of 5.22 and a quick ratio of 5.34. Vapotherm Inc has a fifty-two week low of $13.94 and a fifty-two week high of $24.63. The company has a market cap of $254.61 million and a price-to-earnings ratio of -1.04.
Vapotherm (NYSE:VAPO) last released its earnings results on Monday, July 29th. The company reported ($0.76) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.81) by $0.05. The company had revenue of $11.99 million for the quarter, compared to analyst estimates of $11.90 million. On average, analysts forecast that Vapotherm Inc will post -3.1 earnings per share for the current year.
Several hedge funds and other institutional investors have recently bought and sold shares of the company. American International Group Inc. purchased a new position in shares of Vapotherm in the 4th quarter worth about $61,000. New York State Common Retirement Fund purchased a new position in shares of Vapotherm in the 4th quarter worth about $118,000. Deutsche Bank AG purchased a new position in shares of Vapotherm in the 4th quarter worth about $121,000. Barclays PLC purchased a new position in shares of Vapotherm in the 4th quarter worth about $142,000. Finally, Marshall Wace North America L.P. purchased a new position in shares of Vapotherm in the 1st quarter worth about $161,000. Hedge funds and other institutional investors own 47.13% of the company’s stock.
Vapotherm Company Profile
Vapotherm, Inc, a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface.
Featured Story: Does the Step Transaction Doctrine Affect a Backdoor Roth IRA?
Receive News & Ratings for Vapotherm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vapotherm and related companies with MarketBeat.com's FREE daily email newsletter.